A coterie of Mayne Pharma holders reckons US bidder Cosette's $600 million tilt does not reflect the upside of the improving Mayne business.

Findings from the first 500 patients treated with the Trilogy system met noninferiority for both safety and efficacy.

Over 80% of these fatalities result from heart attacks and strokes. December is notorious for being the biggest month for heart attacks, with one of the most dangerous being the widowmaker heart ...

Severely calcified coronary artery lesions are encountered increasingly frequently in clinical practice. The technical challenges faced by the interventional cardiologist in the treatment of these ...

A new study by researchers at Intermountain Health in Salt Lake City aims to determine the best method to screen and evaluate patients who are at risk of developing coronary heart disease and which ...